行业研究报告

Capgemini-生命科学绿地建设(英)-2024

2024-12生物技术12 页Capgemini

Life Sciences greenfield builds The pharmaceutical manufacturing industry is in the midst of a transformation. As new therapies, precision medicines, and biologics continue to expand, manufacturers are increasingly focused on building advanced

报告摘要

Life Sciences greenfield builds The pharmaceutical manufacturing industry is in the midst of a transformation. As new therapies, precision medicines, and biologics continue to expand, manufacturers are increasingly focused on building advanced

报告信息

文件全名
《Capgemini-生命科学绿地建设(英)-2024-12页.pdf》
适合读者
战略规划行业研究员
核心数据
  1. From 2021 to 2024, capital investment grew by more than 25% annually, with leading companies like Novo Nordisk,
核心议题
生命科学

常见问题

《Capgemini-生命科学绿地建设(英)-2024》主要包含哪些内容?

Life Sciences greenfield builds The pharmaceutical manufacturing industry is in the midst of a transformation. As new therapies, precision medicines, and biologics continue to expand, manufacturers are increasingly focused on building advanced核心数据:From 2021 to 2024, capital investment grew by more than 25% annually, with leading companies like Novo Nordisk,。

这份报告由哪家机构发布?

本报告由Capgemini发布,发布于 2024 年。

这份报告覆盖哪一年、篇幅多大?

覆盖 2024 年,全文共 12 页。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合战略规划、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了生命科学等议题。

继续阅读

同分类报告

查看全部 →
📱 登录